News

Fierce Pharma20h
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up.
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Stocktwits on MSN9h
CDC Greenlights Vaccines From Pfizer, Moderna, GSK Amid Shakeup Of Advisory Panel
The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...
Medscape3h
Efficacy and Toxicity Seen With MIRV in Platinum-Sensitive Ovarian Cancer
New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...
Newseria BIZNES6h
Paresthesia Treatment Market: Heading for $7.9 Billion by 2031 — and New Therapies Are Already Reshaping the Landscape
PORTLAND, OR, UNITED STATES, July 3, 2025 /EINPresswire.com/ -- (Global value: USD 5.4 billion (2021) → USD 7.9 billion (2031) | CAGR 3.8 %) The growth of paresthesia treatment market share is driven ...
American Council on Science and Health9hOpinion
Dangerous Gamble: U.S. Abandons Bird Flu Vaccine Preparedness
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...